Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Destiny Pharma Fundamentals

Company Name Destiny Pharma Last Updated 22 Oct 2020
Industry Health Care Sector Biotechnology
Shares in Issue (m) 43.87 Market Cap (£m) 36.63
PE Ratio -7.80 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS -10.70 EPS Growth (%) 10.08
PEG -0.77 DPS Growth (%) n/a
Debt Ratio 0.00 Debt Equity Ratio 0.00
Net Gearing -78.09 Gross Gearing 9.33
Asset Equity Ratio 1.10 Cash Equity Ratio 96.40
Quick Ratio 10.68 Current Ratio 10.68
Price To Book Value 4.72 ROCE -71.13

Destiny Pharma Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Destiny Pharma Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 0 0 0
Intangible Assets 0 0 0
Investments 0 0 0
Total Fixed Assets 0 0 0
Stocks 0 0 0
Debtors 1 1 0
Cash & Equivalents 7 7 12
Other Assets 0 5 5
Total Assets 9 13 17
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 1 1 0
Creditors after 1 year 0 0 0
Other Liabilities 0 0 0
Total Liabilities 1 1 0
Net assets 8 12 17
Equity (£m) 2019 2018 2017
Called up share capital 0 0 0
Share Premium 17 17 17
Profit / Loss -6 -6 -3
Other Equity 0 0 0
Preference & Minorities 0 0 0
Total Capital Employed 8 12 17
Ratios 2019 2018 2017
Debt Ratio 0.00 0.00 0.00
Debt-to-Equity 0.00 0.00 0.00
Net Gearing -78.09 -47.94 -66.31
Gross Gearing 9.33 6.13 2.32
Assets / Equity 1.10 1.07 1.02
Cash / Equity 96.40 57.61 70.26
EPS -10.70 -11.90 -8.40
Cash Flow (£m) 2019 2018 2017
Cash from operating activities -5 -5 -2
Cashflow before financing 0 -5 -7
Increase in Cash 0 -5 10
Income (£m) 2019 2018 2017
Turnover 0 0 0
Cost of sales 0 0 0
Gross Profit 0 0 0
Operating Profit -6 -6 -3
Pre-Tax profit -6 -6 -3
Profit / Loss for the year 0 0 0

Destiny Pharma Company Background

Sector Biotechnology
Activities Destiny Pharma plc is an established, clinical stage, innovative biotechnology company focused on the development of novel medicines that represent a new approach to the treatment of infectious disease. These potential new medicines are being developed to address the need for new drugs for the prevention and treatment of life-threatening infections caused by antibiotic-resistant bacteria, often referred to as superbugs. Tackling anti-microbial resistance has become a global imperative recognised by the World Health Organisation (WHO) and the United Nations, as well as the G7 and the G20 countries.
Latest Interim Date 17 Sep 2020
Latest Fiscal Year End Date 29 Apr 2020

Destiny Pharma Directors

Appointed Director Position
2017-01-20 Neil Robert Clark Chief Executive Officer
2018-10-24 Shaun Claydon Chief Financial Officer
1996-06-17 Dr William Guy Love Chief Scientific Officer
2017-12-01 Dr Huai Zheng Peng Executive Director
2018-06-21 Philip Nicholas Rodgers Non-Executive Chairman
1997-03-12 Peter Morgan Non-Executive Director
2020-01-01 Dr Debra Stephanie Barker Non-Executive Director

Destiny Pharma Contact Details

Company Name Destiny Pharma
Company Address Unit 36, Sussex Innovation Centre, Falmer, Brighton BN1 9SB.
Company Telephone +44 (0)1273 704 440
Company Website http://www.destinypharma.com/

Destiny Pharma Advisors

Auditor Name Crowe Clark Whitehill LLP
Auditor Address St Brides House, 10 Salisbury Square, London EC4Y 8EH.
Auditor Website http://www.croweclarkwhitehill.co.uk/
Auditor Telephone +44 (0)20 7842 7100
Registrar Name Link Asset Services
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.linkassetservices.com/
Registrar Telephone 0870 162 3100
Broker Name Cantor Fitzgerald Europe
Broker Address 17 Crosswall, London E14 5RD.
Broker Website http://www.cantor.com/
Broker Telephone +44(0)20 7894 7000
Adviser Name Cantor Fitzgerald Europe
Adviser Address 17 Crosswall, London E14 5RD.
Adviser Website http://www.cantor.com/
Adviser Telephone +44(0)20 7894 7000
Solicitor Name Irwin Mitchell
Solicitor Address 40 Holborn Viaduct, London EC1N 2PZ.
Solicitor Website http://www.irwinmitchell.com/
Solicitor Telephone 0870 1500 100
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a